Cargando…
Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864440/ https://www.ncbi.nlm.nih.gov/pubmed/35202585 http://dx.doi.org/10.1016/j.ccell.2022.02.010 |
| _version_ | 1784655462126321664 |
|---|---|
| author | Abid, Muhammad Bilal Rubin, Micah Ledeboer, Nathan Szabo, Aniko Longo, Walter Mohan, Meera Shah, Nirav N. Fenske, Timothy S. Abedin, Sameem Runaas, Lyndsey D’Souza, Anita Chhabra, Saurabh Dhakal, Binod Hamadani, Mehdi |
| author_facet | Abid, Muhammad Bilal Rubin, Micah Ledeboer, Nathan Szabo, Aniko Longo, Walter Mohan, Meera Shah, Nirav N. Fenske, Timothy S. Abedin, Sameem Runaas, Lyndsey D’Souza, Anita Chhabra, Saurabh Dhakal, Binod Hamadani, Mehdi |
| author_sort | Abid, Muhammad Bilal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8864440 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88644402022-02-23 Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients Abid, Muhammad Bilal Rubin, Micah Ledeboer, Nathan Szabo, Aniko Longo, Walter Mohan, Meera Shah, Nirav N. Fenske, Timothy S. Abedin, Sameem Runaas, Lyndsey D’Souza, Anita Chhabra, Saurabh Dhakal, Binod Hamadani, Mehdi Cancer Cell Letter Elsevier Inc. 2022-04-11 2022-02-23 /pmc/articles/PMC8864440/ /pubmed/35202585 http://dx.doi.org/10.1016/j.ccell.2022.02.010 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Abid, Muhammad Bilal Rubin, Micah Ledeboer, Nathan Szabo, Aniko Longo, Walter Mohan, Meera Shah, Nirav N. Fenske, Timothy S. Abedin, Sameem Runaas, Lyndsey D’Souza, Anita Chhabra, Saurabh Dhakal, Binod Hamadani, Mehdi Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients |
| title | Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients |
| title_full | Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients |
| title_fullStr | Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients |
| title_full_unstemmed | Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients |
| title_short | Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients |
| title_sort | efficacy of a third sars-cov-2 mrna vaccine dose among hematopoietic cell transplantation, car t cell, and bite recipients |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864440/ https://www.ncbi.nlm.nih.gov/pubmed/35202585 http://dx.doi.org/10.1016/j.ccell.2022.02.010 |
| work_keys_str_mv | AT abidmuhammadbilal efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT rubinmicah efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT ledeboernathan efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT szaboaniko efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT longowalter efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT mohanmeera efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT shahniravn efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT fensketimothys efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT abedinsameem efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT runaaslyndsey efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT dsouzaanita efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT chhabrasaurabh efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT dhakalbinod efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients AT hamadanimehdi efficacyofathirdsarscov2mrnavaccinedoseamonghematopoieticcelltransplantationcartcellandbiterecipients |